After TTIP Round, “Important” Differences Remain On GIs, Negotiators Say 23/10/2015 by William New, Intellectual Property Watch Leave a Comment At the conclusion of another round of talks for a bilateral trade agreement in Miami today, Europe and the United States negotiators said they remain far apart on the issue of protection of geographical indications. But they made progress on pharmceuticals and medical products, they said.
CEIPI Event – Is Copyright In The EU Fit For The 21st Century? 21/10/2015 by Intellectual Property Watch Leave a Comment The Center for International Intellectual Property Studies (CEIPI) of the University of Strasbourg welcomes the Vice-President of the European Commission in charge of the Digital Single Market, Andrus Ansip, for a conference-debate on the topic of the future copyright reform in the EU: “Is copyright in the EU fit for the 21st century?”.
Standards Needed For IP Value To Be Recognised By Banks, IP Offices Say 20/10/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment Valuation of intellectual property is of growing importance to small and medium-sized enterprises in getting loans from financial institutions, IP office representatives said at a side event to the World Intellectual Property Organisation General Assembly this month.
EPO Still In Turmoil As Supervisory Body Backs Dismissal Of High-Level Staff 20/10/2015 by Intellectual Property Watch Leave a Comment The European Patent Organisation has been in turmoil for years facing serious staff dissent and complaints aimed at EPO President Benoît Battistelli of France. The EPO’s effort appears to have intensified in recent months, and on Friday the EPO Administrative Council, the agency’s supervisory body, announced an action to back Battistelli and endorsed a request for the dismissal of a high-level staff member. The action sent critics to new levels of criticism.
“The Brain Is The Next Frontier,” Bioethics Futurist Says, Raising New Societal Challenges 19/10/2015 by Marianna Drake for Intellectual Property Watch 6 Comments At the recent TEDx CERN event, Intellectual Property Watch caught up with bioethicist and legal philosopher Matthew Liao, to reflect on challenging moral questions raised by new advances in computing and neuroscience allowing for the manipulation of human thoughts and memories. Liao reflected on whether we should use drugs and technology to erase traumatic memories, and if individuals have a moral obligation to themselves to remember certain events.
TEDx CERN: Academics, Artists And Scientists “Break The Rules” For Future 19/10/2015 by Marianna Drake for Intellectual Property Watch 1 Comment Speakers from the fields of academia, arts and science brought their visions of a new world and the role the next generation must play in shaping it to the audience of TEDx CERN on 9 October. The visionary speakers break the boundaries of academic research to propose innovative solutions for the future that take into account today’s limitations.
Health Groups Urge EU Commission To Safeguard Access To Medicines In Developing Countries 14/10/2015 by Intellectual Property Watch Leave a Comment Health Action International (HAI) and Médecins Sans Frontières (MSF – Doctors without Borders) today issued a joint report on European Union commitments to safeguard access to medicines. Their report [pdf] comes in the context of the revision of the European Union’s trade and investment policy, released today.
European Council Backs LDC Extension At WTO 13/10/2015 by Intellectual Property Watch Leave a Comment The European Council has confirmed that it will support the request of least developed countries at the World Trade Organization for the extension of a waiver of intellectual property obligations for pharmaceutical products.
Trademark: Low Visual Similarity, No Phonetic Similarity, But Still Confusingly Similar? 12/10/2015 by Intellectual Property Watch Leave a Comment In 2007, a Polish company filed an application for a composite European Community trademark comprising the representation in colour of a crocodilian with its torso made up from the letters of the word “kajman” in printed characters for, among others, classes 18 (leather goods) and 25 (clothing, footwear).
Chatham House Report On Antibiotics Gives Evidence For Drug R&D Delinkage 09/10/2015 by Catherine Saez, Intellectual Property Watch 1 Comment A new report from Chatham House presenting suggestions for novel business models for antibiotics calls for models in which the return on investment in research and development is not dependent on the volume of sales, also known as delinkage.